First Trust Heitman Global Prime Real Estate ETF

$3.14

Key Metrics

TER N/A
Distribution policy N/A
Fund size N/A
Inception date N/A
Holdings 0
Fund currency USD
Fund domicile N/A
Provider First Trust

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Heitman Global Prime Real Estate ETF PRME
Fund Size
-
Dividend
0.0%
Fees
-

Historical Return

Last updated: Jun 01, 2026
1 Year +198.3% +0.0% Div
3 Years (avg.) -37.8% +0.0% Div
5 Years (avg.) -25.4% +0.0% Div

Risk & Analysis Metrics

Last updated: Jun 01, 2026

Volatility

93.51% 1 Year
90.15% 3 Years
87.36% 5 Years
87.36% 10 Years

Max Drawdown

-59.52% 1 Year
-93.26% 3 Years
-94.55% 5 Years
-94.55% 10 Years

Sharpe Ratio

1.46 1 Year
-0.11 3 Years
-0.07 5 Years
-0.07 10 Years

Return Triangle (Heatmap)

Last updated: Jun 01, 2026
2022 2023 2024 2025
2022 20.9% -21.9% -41.2% -30.3%
2023 -49.5% -59.0% -42.0%
2024 -66.7% -37.8%
2025 16.1%

Distributions

*by ETF Portfolio Weight Last updated: Not yet calculated

Profit Margin Distribution

< 0%
0%
1y 3y N/A N/A
0 - 5%
0%
1y 3y N/A N/A
5 - 10%
0%
1y 3y N/A N/A
10 - 15%
0%
1y 3y N/A N/A
15 - 20%
0%
1y 3y N/A N/A
20 - 30%
0%
1y 3y N/A N/A
30 - 40%
0%
1y 3y N/A N/A
> 40%
0%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
0%
1y 3y N/A N/A
0 - 10
0%
1y 3y N/A N/A
10 - 15
0%
1y 3y N/A N/A
15 - 20
0%
1y 3y N/A N/A
20 - 25
0%
1y 3y N/A N/A
25 - 35
0%
1y 3y N/A N/A
35 - 50
0%
1y 3y N/A N/A
> 50
0%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
0.0%
1y 3y N/A N/A
Large Cap
0.0%
1y 3y N/A N/A
Mega Cap
0.0%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Not yet calculated
N/A Top 5 Holdings
N/A Top 10 Holdings
N/A Top 50 Holdings
N/A Top 100 Holdings

Latest News

almost 2 years ago • zacks.com

Prime Medicine (PRME) Gains 16.4% in 3 Months: Buy Now or Wait?

While Prime Medicine (PRME) exhibits potential with its encouraging pipeline progress, the current cash position warrants caution. We advise a wait...
almost 2 years ago • Seeking Alpha

Prime Medicine Stock: Only For The Most Patient Of Investors

Prime Medicine, Inc., a gene editing firm with several candidates in clinical development, recently upgraded by Citigroup. Click here for more on P...
about 2 years ago • zacks.com

Wall Street Analysts Believe Prime Medicine, Inc. (PRME) Could Rally 120.95%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 121% in Prime Medicine, Inc. (PRME). While the effectivene...

No investments found

This ETF does not have any holdings data available yet.